CURE Pharma inks cannabis licensing agreement with Vanguard Scientific
Author : Saipriya Iyer | Published Date : 2020-02-14
Cure Pharmaceutical, a pharma firm involved in the delivery and development of drugs, recently announced it has inked an agreement for collaboration and licensing with Vanguard Scientific Systems, Inc.
Vanguard is a leading equipment, performance solutions, and systems provider to the botanical extraction industry, that includes both, next-generation GMP compliant CO2 extraction tech- MIDAS XII and CO2 facility solutions that are industrially scaled.
Apparently, the license will give Vanguard the rights to practice the patented cannabis extraction methods of CURE, offering customers the confidence to choose the portfolio of extraction manufacturers of Vanguard.
CURE Pharmaceutical’s CEO, Rob Davidson commented that the license agreement will give operational freedom to the leader within the supercritical fluid extraction industry. The latter is dedicated to the pharma-grade standards by continuing the company’s licensing strategy that is powered by Cure.
Davidson further added that the company will build on the license and collaborate with Vanguard Scientific experts for the expansion of licensed patent estate to be able to cover the majority of the recent advances within the field.
According to reliable sources, CURE has awarded Vanguard the rights to pending and issued process portfolio and the composition patents for the isolation of all the cannabinoids by utilizing an enhanced supercritical fluid extraction tech that uses CO2 as its solvent. CURE has reportedly reserved the entire rights towards applying the methods in an oral thin film as the patents shall cover the use of cannabis extracts in several dosage forms.
Vanguard Scientific’s CEO, Matthew Anderson stated that CURE leads the innovations in cannabinoid drug delivery and the collaboration and license agreement shall assure the customers while they choose the extraction solutions.
Vanguard Scientific aims to expand its traction within the marketplace by encouraging a focused patented strategy that will offer the clients a wide array of defensible and protected separation capabilities.
About Author
Saipriya Iyer . .
Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i
Related News
Hero MotoCorp under investigation by Ministry of Corporate Affairs
The Indian Ministry of Corporate Affairs has reportedly ordered a probe into Hero MotoCorp to examine its association with an external vendor regarding alleged fund diversion. The objective of the investigation, conducted in the "public interest," is to evaluate the Hero MotoCorp owners... Read More>>
UK: Residents receive bills of up to £49,000 after Ovo acquires SSE
Customers of Ovo, the energy supplier were reportedly left shocked when they received energy bills of up to £49,000, due to data errors that led to overinflated energy bills for some residents. Ovo accepted that some of its customers have been affected by erroneous meter readings, and it bl... Read More>>
Bob Iger returns to Disney as CEO less than a year post retirement
Bob Iger, the ex-CEO of Walt Disney Co., is reportedly coming back to the mass media giant less than a year after his retirement. The surprise announcement comes at a time when Disney is struggling to earn profits from its streaming TV services. According to a statement released by Disney late Su... Read More>>